Baudax Bio, Inc.'s stock has declined approximately -98.72515% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.29.
| Beta (5Y) | N/A |
| 52-Week Price Change | -98.72515% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.29 |
| Average Volume (20 Days) | N/A |
Baudax Bio, Inc.'s most recent stock split took place on December 1, 2022 with a 40:1 split ratio.
| Last Split Date | 12/1/2022 |
| Split Ratio | 40:1 |